Zus Health Accepted as a Candidate QHIN Under TEFCAMilestone advances the shared health data platform toward direct national-network connectivity
Zus Health Achieves HITRUST r2 Certification, Demonstrating Commitment to Cybersecurity and Information ProtectionBOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Zus Health, the healthcare data platform that unifies scattered data into an always-on common patient record, today announced that its shared FHIR-native platform residing at Amazon Web Services (AWS) US-East-1 and used by thousands of healthcare providers has earned r2 certified status from HITRUST for cybersecurity and information protection.
Zus Health Helps Value-Based Care Organizations Capture Accurate Risk with Intuitive, Evidence-Based WorkflowsBOSTON, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Zus Health, the always-on data platform that unifies every patient record into a single, comprehensive view, today announced new capabilities for accurately capturing a patient’s burden of illness.
Zus Health Celebrates Unprecedented Growth, Announcing New Clients and AI-Powered InnovationsBOSTON, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Zus Health is proud to announce a transformative milestone in its journey to reshape care delivery through data interoperability and actionable insights. Over the past year, Zus has grown its revenue eightfold, with 12 new client partnerships signed in the last quarter alone, further solidifying its position as a critical player in advancing value-based care. With over 60 live customers and cutting-edge AI-powered innovations, Zus has truly arrived as a driving force in healthcare transformation.
Zus Health Closes $34M Series A Led by Andreessen Horowitz (a16z); Participation from F-Prime Capital, Maverick Ventures and Others
Zus Health (“Zus” pronounced Zoos like the father of Athena), a Jonathan Bush-founded company focused on creating the industry’s first shared development platform backed by a shared data record, today announced its launch and the close of a $34M Series A financing led by Andreessen Horowitz (a16z). F-Prime Capital, Maverick Ventures, Rock Health, Martin Ventures and Oxeon Investments also participated in the round.
